Literature DB >> 29084780

Mechanisms, Consequences, and Prevention of Coronary Graft Failure.

Mario Gaudino1, Charalambos Antoniades2, Umberto Benedetto2, Saswata Deb2, Antonino Di Franco2, Gabriele Di Giammarco2, Stephen Fremes2, David Glineur2, Juan Grau2, Guo-Wei He2, Daniele Marinelli2, Lucas B Ohmes2, Carlo Patrono2, John Puskas2, Robert Tranbaugh2, Leonard N Girardi2, David P Taggart2.   

Abstract

Graft failure occurs in a sizeable proportion of coronary artery bypass conduits. We herein review relevant current evidence to give an overview of the incidence, pathophysiology, and clinical consequences of this multifactorial phenomenon. Thrombosis, endothelial dysfunction, vasospasm, and oxidative stress are different mechanisms associated with graft failure. Intrinsic morphological and functional features of the bypass conduits play a role in determining failure. Similarly, characteristics of the target coronary vessel, such as the severity of stenosis, the diameter, the extent of atherosclerotic burden, and previous endovascular interventions, are important determinants of graft outcome and must be taken into consideration at the time of surgery. Technical factors, such as the method used to harvest the conduits, the vasodilatory protocol, the storage solution, and the anastomotic technique, also play a major role in determining graft success. Furthermore, systemic atherosclerotic risk factors, such as age, sex, diabetes mellitus, hypertension, and dyslipidemia, have been variably associated with graft failure. The failure of a coronary graft is not always correlated with adverse clinical events, which vary according to the type, location, and reason for failed graft. Intraoperative flow verification and secondary prevention using antiplatelet and lipid-lowering agents can help reducing the incidence of graft failure.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  CABG; graft failure; myocardial revascularization

Mesh:

Year:  2017        PMID: 29084780     DOI: 10.1161/CIRCULATIONAHA.117.027597

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

Review 1.  Cardiac surgery 2017 reviewed.

Authors:  Torsten Doenst; Hristo Kirov; Alexandros Moschovas; David Gonzalez-Lopez; Rauf Safarov; Mahmoud Diab; Steffen Bargenda; Gloria Faerber
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

2.  Ticagrelor and aspirin increased vein graft patency after coronary artery bypass grafting but does it matter?

Authors:  Diane Zlotnik; Bernard Cholley; Anne Godier
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Doubling up on antiplatelet therapy after CABG: changing practice ASAP after DACAB?

Authors:  Daniel J F M Thuijs; Milan Milojevic; Stuart J Head
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Pivotal contemporary trials of percutaneous coronary intervention vs. coronary artery bypass grafting: a surgical perspective.

Authors:  Janet M C Ngu; Louise Y Sun; Marc Ruel
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 5.  Dual inflow, total-arterial, anaortic, off-pump coronary artery bypass grafting: how to do it.

Authors:  Fabio Ramponi; Michael Seco; James B Edelman; Andrew G Sherrah; Paul G Bannon; R John L Brereton; Michael K Wilson; Michael P Vallely
Journal:  Ann Cardiothorac Surg       Date:  2018-07

6.  Orbital Atherectomy and Heavily Calcified Saphenous Vein Graft Intervention.

Authors:  Maheedhar Gedela; Shenjing Li; Udit Bhatnagar; Adam Stys; Tomasz Stys
Journal:  Tex Heart Inst J       Date:  2020-02-01

7.  Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.

Authors:  Qiang Zhao; Yunpeng Zhu; Zhiyun Xu; Zhaoyun Cheng; Ju Mei; Xin Chen; Xiaowei Wang
Journal:  JAMA       Date:  2018-04-24       Impact factor: 56.272

Review 8.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

9.  Effects of the different-sized external stents on vein graft intimal hyperplasia and inflammation.

Authors:  Qi Yang; Dong Lei; Shixing Huang; Yi Yang; Yang Yang; Xiaofeng Ye; Zhengwei You; Qiang Zhao
Journal:  Ann Transl Med       Date:  2020-02

10.  Association of hypoxia and mitochondrial damage associated molecular patterns in the pathogenesis of vein graft failure: a pilot study.

Authors:  Finosh G Thankam; Joseph G Ayoub; Mohamed M Radwan Ahmed; Aleem Siddique; Thomas C Sanchez; Rafael A Peralta; Thomas J Pennington; Devendra K Agrawal
Journal:  Transl Res       Date:  2020-08-28       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.